Avandia User's Warranty Violation Suit Flops In 3rd Circ.
The Third Circuit on Tuesday refused to revive a putative class action accusing GlaxoSmithKline PLC of violating the warranty on its diabetes drug Avandia, ruling a label declaring the drug "safe...To view the full article, register now.
Already a subscriber? Click here to view full article